647 related articles for article (PubMed ID: 22235057)
1. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.
Tomljenovic L; Shaw CA
Lupus; 2012 Feb; 21(2):223-30. PubMed ID: 22235057
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity following hepatitis B vaccine as part of the spectrum of 'Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.
Zafrir Y; Agmon-Levin N; Paz Z; Shilton T; Shoenfeld Y
Lupus; 2012 Feb; 21(2):146-52. PubMed ID: 22235045
[TBL] [Abstract][Full Text] [Related]
3. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism?
Tomljenovic L; Shaw CA
J Inorg Biochem; 2011 Nov; 105(11):1489-99. PubMed ID: 22099159
[TBL] [Abstract][Full Text] [Related]
4. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.
Perricone C; Colafrancesco S; Mazor RD; Soriano A; Agmon-Levin N; Shoenfeld Y
J Autoimmun; 2013 Dec; 47():1-16. PubMed ID: 24238833
[TBL] [Abstract][Full Text] [Related]
6. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines.
Hehme N; Engelmann H; Künzel W; Neumeier E; Sänger R
Med Microbiol Immunol; 2002 Dec; 191(3-4):203-8. PubMed ID: 12458361
[TBL] [Abstract][Full Text] [Related]
7. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
8. Adjuvants and autoimmunity.
Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
Lupus; 2009 Nov; 18(13):1217-25. PubMed ID: 19880572
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Semrl S; Ambrožič A
Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
[TBL] [Abstract][Full Text] [Related]
10. Vaccines, adjuvants and autoimmunity.
Guimarães LE; Baker B; Perricone C; Shoenfeld Y
Pharmacol Res; 2015 Oct; 100():190-209. PubMed ID: 26275795
[TBL] [Abstract][Full Text] [Related]
11. The path to a successful vaccine adjuvant--'the long and winding road'.
O'Hagan DT; De Gregorio E
Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
[TBL] [Abstract][Full Text] [Related]
12. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
13. Infection, vaccines and other environmental triggers of autoimmunity.
Molina V; Shoenfeld Y
Autoimmunity; 2005 May; 38(3):235-45. PubMed ID: 16126512
[TBL] [Abstract][Full Text] [Related]
14. On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives.
Pellegrino P; Clementi E; Radice S
Autoimmun Rev; 2015 Oct; 14(10):880-8. PubMed ID: 26031899
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.
Wu J; Liu SZ; Dong SS; Dong XP; Zhang WL; Lu M; Li CG; Zhou JC; Fang HH; Liu Y; Liu LY; Qiu YZ; Gao Q; Zhang XM; Chen JT; Zhong X; Yin WD; Feng ZJ
Vaccine; 2010 Aug; 28(38):6221-7. PubMed ID: 20638454
[TBL] [Abstract][Full Text] [Related]
16. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
Shoenfeld Y; Aron-Maor A
J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110
[TBL] [Abstract][Full Text] [Related]
17. Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants.
Masson JD; Crépeaux G; Authier FJ; Exley C; Gherardi RK
J Inorg Biochem; 2018 Apr; 181():87-95. PubMed ID: 29307441
[TBL] [Abstract][Full Text] [Related]
18. Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?
Shaw CA; Li D; Tomljenovic L
Immunotherapy; 2014; 6(10):1055-71. PubMed ID: 25428645
[TBL] [Abstract][Full Text] [Related]
19. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants.
Shoenfeld Y; Agmon-Levin N
J Autoimmun; 2011 Feb; 36(1):4-8. PubMed ID: 20708902
[TBL] [Abstract][Full Text] [Related]
20. Infants' exposure to aluminum from vaccines and breast milk during the first 6 months.
Dórea JG; Marques RC
J Expo Sci Environ Epidemiol; 2010 Nov; 20(7):598-601. PubMed ID: 20010978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
